Spoken Alpha
PAVM
PAVmed Inc.
Overview
PAVmed Inc. operates a diversified life sciences company developing and commercializing medical devices, diagnostics, and digital health solutions through independently financed subsidiaries.
PAVmed Inc is a Healthcare company operating in Medical Devices with a $14.6M market cap.
PAVM beat consensus EPS by 0.4% in Q2 FY2026, reported Aug 13, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-158 Q&A exchanges
- Q4 FY2025Earnings2026-03-305 Q&A exchanges
- Q3 FY2025Earnings2025-11-137 Q&A exchanges
- Q1 FY2025Earnings2025-05-158 Q&A exchanges
- Q4 FY2024Earnings2025-03-258 Q&A exchanges
- Q3 FY2024Earnings2024-11-148 Q&A exchanges
- Q2 FY2024Earnings2024-08-1312 Q&A exchanges
- Q1 FY2024Earnings2024-05-145 Q&A exchanges
- Q4 FY2023Earnings2024-03-2710 Q&A exchanges
- Q3 FY2023Earnings2023-11-1514 Q&A exchanges
- Q2 FY2023Earnings2023-08-1614 Q&A exchanges
- Q1 FY2023Earnings2023-05-179 Q&A exchanges
- Q4 FY2022Earnings2023-03-1517 Q&A exchanges
- Q3 FY2022Earnings2022-11-1514 Q&A exchanges
- Q2 FY2022Earnings2022-08-1613 Q&A exchanges
- Q1 FY2022Earnings2022-05-1211 Q&A exchanges
- Q4 FY2021Earnings2022-03-2918 Q&A exchanges
- Q3 FY2021Earnings2021-11-1620 Q&A exchanges
- Q2 FY2021Earnings2021-08-1210 Q&A exchanges
- Q1 FY2021Earnings2021-05-1726 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-13EPS$-0.42 vs $-0.66+36.4%Rev$33.0K vs ——EODHD
- Q1 FY20262026-05-13EPS$-1.17 vs $-0.69-69.6%Rev$22.0K vs ——EODHD
- Q4 FY20252026-03-29EPS$-1.05 vs $-4.50+76.7%Rev$52.0K vs ——EODHD
- Q3 FY20252025-11-11EPS$-0.60 vs $-6.00+90.0%Rev$5.0K vs ——EODHD
- Q2 FY20252025-08-13EPS$-1.50 vs $-7.50+80.0%Rev$6.0K vs ——EODHD
- Q1 FY20252025-05-14EPS$-0.14 vs $-0.31+54.8%Rev$8.0K vs ——EODHD
- Q4 FY20242025-03-23EPS$-0.19 vs $-0.40+52.5%Rev$10.0K vs ——EODHD
- Q3 FY20242024-11-13EPS$-16.20 vs $-39.00+58.5%Rev$996.0K vs ——EODHD
- Q2 FY20242024-08-11EPS$-6.00 vs $-40.20+85.1%Rev$979.0K vs ——EODHD
- Q1 FY20242024-05-12EPS$-2.62 vs $-1.67-56.9%Rev$1.0M vs ——EODHD
- Q4 FY20232024-03-24EPS$-46.92 vs $-53.70+12.6%Rev$1.0M vs ——EODHD
- Q3 FY20232023-11-12EPS$-37.45 vs $-63.00+40.6%Rev$791.0K vs ——EODHD
- Q2 FY20232023-08-13EPS$-46.41 vs $-69.75+33.5%Rev$166.0K vs ——EODHD
- Q1 FY20232023-05-14EPS$-54.86 vs $-74.25+26.1%Rev$446.0K vs ——EODHD
- Q4 FY20222023-03-12EPS$-0.23 vs $-0.25+8.0%Rev$112.0K vs ——EODHD
- Q3 FY20222022-11-13EPS$-67.50 vs $-105.75+36.2%Rev$76.0K vs ——EODHD
- Q2 FY20222022-08-14EPS$-76.50 vs $-90.00+15.0%Rev$0 vs ——EODHD
- Q1 FY20222022-05-11EPS$-63.00 vs $-85.50+26.3%Rev$189.0K vs ——EODHD
- Q4 FY20212022-03-28EPS$-0.20 vs $-0.15-33.3%Rev$300.0K vs ——EODHD
- Q3 FY20212021-11-15EPS$-45.00 vs $-42.75-5.3%Rev$200.0K vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-13 | $-0.42 | $-0.66 | +36.4% | $33.0K | — | — | EODHD |
| Q1 FY2026 | 2026-05-13 | $-1.17 | $-0.69 | -69.6% | $22.0K | — | — | EODHD |
| Q4 FY2025 | 2026-03-29 | $-1.05 | $-4.50 | +76.7% | $52.0K | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $-0.60 | $-6.00 | +90.0% | $5.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-1.50 | $-7.50 | +80.0% | $6.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.14 | $-0.31 | +54.8% | $8.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-23 | $-0.19 | $-0.40 | +52.5% | $10.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-13 | $-16.20 | $-39.00 | +58.5% | $996.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-11 | $-6.00 | $-40.20 | +85.1% | $979.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-2.62 | $-1.67 | -56.9% | $1.0M | — | — | EODHD |
| Q4 FY2023 | 2024-03-24 | $-46.92 | $-53.70 | +12.6% | $1.0M | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-37.45 | $-63.00 | +40.6% | $791.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-46.41 | $-69.75 | +33.5% | $166.0K | — | — | EODHD |
| Q1 FY2023 | 2023-05-14 | $-54.86 | $-74.25 | +26.1% | $446.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-12 | $-0.23 | $-0.25 | +8.0% | $112.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-67.50 | $-105.75 | +36.2% | $76.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-76.50 | $-90.00 | +15.0% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-63.00 | $-85.50 | +26.3% | $189.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-28 | $-0.20 | $-0.15 | -33.3% | $300.0K | — | — | EODHD |
| Q3 FY2021 | 2021-11-15 | $-45.00 | $-42.75 | -5.3% | $200.0K | — | — | EODHD |
Source: EODHD. PAVM reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Lishan AklogCEO10 yr 7 mo20 callsCurrent
- Dennis M McGrathCFO1 yr 2 mo20 callsCurrent
- Shaun O'NeilCOO4 yr 9 mono recorded callsCurrent
- Victoria Tou-ho LeeChief Medical Officer8 mono recorded callsCurrent
- Michael Adam GordonGeneral Counsel4 yr 6 mono recorded callsCurrent
- Richard F FitzgeraldCFO5 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PAVM.
$ curl https://api.spokenalpha.com/v1/companies/PAVMFAQ
Frequently asked about PAVM
Where can I find PAVmed Inc.'s (PAVM) earnings call transcripts?
Spoken Alpha indexes PAVM's earnings call transcripts at https://spokenalpha.com/companies/PAVM. Each call links to attributed speakers and parsed analyst Q&A. PAVmed Inc.'s own investor relations page is at https://ir.pavmed.com/.
When was PAVmed Inc.'s most recent earnings call?
PAVmed Inc. (PAVM) held its most recent earnings call on 2026-05-15, covering fiscal Q1 2026.
What sector is PAVM in?
PAVmed Inc. (PAVM) operates in the Healthcare sector (Medical Devices industry).